15-34793000-C-T

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_005159.5(ACTC1):​c.454+245G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.596 in 568,658 control chromosomes in the GnomAD database, including 101,963 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.62 ( 29715 hom., cov: 32)
Exomes 𝑓: 0.59 ( 72248 hom. )

Consequence

ACTC1
NM_005159.5 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -3.56

Publications

14 publications found
Variant links:
Genes affected
ACTC1 (HGNC:143): (actin alpha cardiac muscle 1) Actins are highly conserved proteins that are involved in various types of cell motility. Polymerization of globular actin (G-actin) leads to a structural filament (F-actin) in the form of a two-stranded helix. Each actin can bind to four others. The protein encoded by this gene belongs to the actin family which is comprised of three main groups of actin isoforms, alpha, beta, and gamma. The alpha actins are found in muscle tissues and are a major constituent of the contractile apparatus. Defects in this gene have been associated with idiopathic dilated cardiomyopathy (IDC) and familial hypertrophic cardiomyopathy (FHC). [provided by RefSeq, Jul 2008]
GJD2-DT (HGNC:55560): (GJD2 divergent transcript)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 15-34793000-C-T is Benign according to our data. Variant chr15-34793000-C-T is described in ClinVar as Benign. ClinVar VariationId is 677956.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.715 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ACTC1NM_005159.5 linkc.454+245G>A intron_variant Intron 3 of 6 ENST00000290378.6 NP_005150.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ACTC1ENST00000290378.6 linkc.454+245G>A intron_variant Intron 3 of 6 1 NM_005159.5 ENSP00000290378.4

Frequencies

GnomAD3 genomes
AF:
0.622
AC:
94392
AN:
151846
Hom.:
29659
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.722
Gnomad AMI
AF:
0.662
Gnomad AMR
AF:
0.615
Gnomad ASJ
AF:
0.537
Gnomad EAS
AF:
0.538
Gnomad SAS
AF:
0.636
Gnomad FIN
AF:
0.503
Gnomad MID
AF:
0.627
Gnomad NFE
AF:
0.590
Gnomad OTH
AF:
0.611
GnomAD4 exome
AF:
0.586
AC:
244365
AN:
416694
Hom.:
72248
AF XY:
0.589
AC XY:
129414
AN XY:
219844
show subpopulations
African (AFR)
AF:
0.715
AC:
8401
AN:
11756
American (AMR)
AF:
0.603
AC:
10523
AN:
17464
Ashkenazi Jewish (ASJ)
AF:
0.535
AC:
6848
AN:
12794
East Asian (EAS)
AF:
0.547
AC:
15556
AN:
28430
South Asian (SAS)
AF:
0.632
AC:
26998
AN:
42702
European-Finnish (FIN)
AF:
0.502
AC:
13130
AN:
26176
Middle Eastern (MID)
AF:
0.598
AC:
1095
AN:
1830
European-Non Finnish (NFE)
AF:
0.588
AC:
147783
AN:
251512
Other (OTH)
AF:
0.584
AC:
14031
AN:
24030
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
4871
9743
14614
19486
24357
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
760
1520
2280
3040
3800
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.622
AC:
94496
AN:
151964
Hom.:
29715
Cov.:
32
AF XY:
0.617
AC XY:
45834
AN XY:
74274
show subpopulations
African (AFR)
AF:
0.722
AC:
29916
AN:
41432
American (AMR)
AF:
0.615
AC:
9388
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.537
AC:
1864
AN:
3472
East Asian (EAS)
AF:
0.538
AC:
2778
AN:
5160
South Asian (SAS)
AF:
0.635
AC:
3054
AN:
4810
European-Finnish (FIN)
AF:
0.503
AC:
5305
AN:
10546
Middle Eastern (MID)
AF:
0.622
AC:
183
AN:
294
European-Non Finnish (NFE)
AF:
0.590
AC:
40105
AN:
67960
Other (OTH)
AF:
0.616
AC:
1299
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1808
3616
5423
7231
9039
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
774
1548
2322
3096
3870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.595
Hom.:
31874
Bravo
AF:
0.631
Asia WGS
AF:
0.597
AC:
2073
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Jun 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.0090
DANN
Benign
0.66
PhyloP100
-3.6
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2070664; hg19: chr15-35085201; API